AlphaYouEJ
Insider selling
Edward J Dulac III sold $84K of Intellia Therapeutics, Inc. (NTLA) stock
Edward J Dulac III, EVP, Chief Financial Officer of Intellia Therapeutics, Inc. (NTLA), sold 4,677 shares of NTLA stock worth $84K, per an SEC Form 4 filed Jul 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 2, 2026, 4 days before it was made public.
NTLA has moved -30.4% since the trade date, from $17.56 to $12.22 (Sep 21, 2026 close).
- Traded
- Jul 2, 2026
- Disclosed
- Jul 6, 2026
- Filing delay
- 4 days
- Price since
- -30.4%
- Role
- EVP, Chief Financial Officer
- Source
- SEC Form 4
More NTLA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.